Generic Medicine, Labelling and Pharmaceutical Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Generic Medicine

Labelling

Pharmaceutical Companies

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

MARCH 14, 2023

This concerns the quantity of the medicinal product in the packaging, ie, the increase or decrease in the number of units of the product in the outer packaging according to local demands and its labelling, including the leaflet, which should be in the language of the country into which the product is imported.

Packaging

Packaging Generic Medicine Labelling Pharmaceutical Companies

Why are clinical trials struggling with diversity?

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging

Packaging Vaccines Generic Medicine Labelling

Pharmacist Digest

Parallel import of medicinal products: regulatory update

Why are clinical trials struggling with diversity?

Stay Connected